Background: Although calcified coronary lesions are associated with poor outcomes after percutaneous coronary interventions (PCI), randomized data guiding lesion preparation are limited. Small studies suggest potential benefits of super-high-pressure noncompliant balloons (SH-NCB); however, they have not been directly compared with intravascular lithotripsy (IVL). Objectives: The goal of this study was to conduct a randomized comparison of SH-NCBs vs IVL in calcified lesions. Methods: In this open-label, randomized controlled, noninferiority trial with blinded outcomes assessment (ie, the PROBE design), patients aged ≥18 years with calcified coronary lesions were randomly assigned (1:1) to undergo lesion preparation with SH-NCBs or IVL before PCI with drug-eluting stents. All patients were required to undergo optical coherence tomography (OCT). The primary endpoint was final stent expansion (%) according to OCT. Secondary endpoints included procedural success, strategy success, target vessel failure, stent expansion <80%, and safety outcomes (eg, coronary perforation). Results: Between December 21, 2022, and August 11, 2025, a total of 278 patients underwent the randomly assigned study procedure using plaque modification with SH-NCBs or IVL before stent implantation. The majority of patients (68%) had severe calcium based on an OCT Fujino score ≥4. Study procedures involving IVL tended to be longer and require more auxiliary devices compared with SH-NCBs. The median pressure applied with SH-NCBs compared with IVL was 40 atmospheres vs 6 atmospheres. Regarding the primary endpoint of stent expansion, SH-NCBs were noninferior to IVL (85% vs 84%; Pnoninferiority < 0.0001). The results were consistent across all subgroups, including calcium severity. Use of SH-NCBs, compared with IVL, resulted in similar rates of procedural and strategy success. Safety outcomes, specifically coronary perforations, did not differ between the 2 groups. At 30 days’ follow-up, target vessel failure events (including cardiac death, target vessel revascularization, or myocardial infarction) occurred in 4 (2.8%) patients in the SH-NCB group and in 8 (5.7%) patients in the IVL group (HR: 0.50; 95% CI: 0.15 to 1.66; P = 0.26). Conclusions: In calcified coronary lesions, SH-NCBs were noninferior to IVL for stent expansion and exhibited a comparable safety profile in experienced operators using intravascular imaging. (Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of Refractory Coronary Lesions [VICTORY]; NCT05346068).